Cognitive Evolution in Tysabri Treated Multiple Sclerosis Patients

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2011
This study is designed to evaluate the effect of Tysabri on cognition in multiple sclerosis (MS) patients. During a period of 24 months, the study will assess the evolution of cognitive function in Tysabri treated MS patients using the Symbol Digit Modalities Test (SDMT) and the CogState battery of tests.
Epistemonikos ID: 0fcaf3d2a8d649e5e22f437414c1dd3a69c0ee91
First added on: May 11, 2024